Early-stage Detection of LIver, Biliary TRAct and PancReatic Cancers
NCT06139042 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1608
Last updated 2025-02-10
Summary
LIBRARY is a prospective, multi-center, observational study aimed at detecting early liver, biliary tract, and pancreatic cancers by combining assays of cell-free DNA (cfDNA) methylation, serum protein, and microRNA.
Conditions
- Liver Cancer
- Biliary Tract Cancer
- Pancreatic Cancer
Interventions
- DIAGNOSTIC_TEST
-
Blood drawing
The participants had their blood drawn.
Sponsors & Collaborators
-
Guangzhou Burning Rock Dx Co., Ltd.
collaborator INDUSTRY -
Second Affiliated Hospital, School of Medicine, Zhejiang University
lead OTHER
Principal Investigators
-
Weilin Wang, Phd · Second Affiliated Hospital, School of Medicine, Zhejiang University
Eligibility
- Min Age
- 40 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-11-01
- Primary Completion
- 2025-06-30
- Completion
- 2025-12-31
Countries
- China
Study Locations
More Related Trials
-
Hepatobiliary and Pancreatic Tumor Biobank
NCT07344116 ·Status: NOT_YET_RECRUITING
-
A Cohort Study on Screening and Follow-up of High-risk Population of PDAC Based on EUS
NCT05621824 ·Status: NOT_YET_RECRUITING
-
Metabolomic and Immune-Microbiome Profiling for Unresectable Pancreatic Cancer
NCT07036978 ·Status: NOT_YET_RECRUITING
-
Optical and Biochemical Biomarkers in Early Pancreatic Cancer
NCT03404661 ·Status: COMPLETED
-
Establishment of a Predictive Model for Immunotherapy Response in Pancreatic Cancer
NCT07271823 ·Status: ACTIVE_NOT_RECRUITING
-
AssesSment of Early-deteCtion basEd oN liquiD Biopsy in PANCEATIC Cancer (ASCEND-PANCREATIC)
NCT05556603 ·Status: RECRUITING
-
Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer
NCT03260842 ·Status: RECRUITING
-
A Clinical Study of BRCA and DNA Damage Repair Genes in Blood Samples of Chinese Pancreatic Cancer Patients
NCT05138302 ·Status: UNKNOWN
-
The Role of ctDNA, PVT1 and ROS in Diagnosis and Treatment of Gastrointestinal and Hepatobiliary Pancreatic Cancer
NCT03076502 ·Status: UNKNOWN
-
Surgery for Pancreatic Tumors and Collection of Tumor Tissue for Study
NCT00100321 ·Status: TERMINATED
-
Multicenter Study of Circulating Tumor DNA in Patients With Pancreatic Cancer Using a Personalized Panel
NCT06043921 ·Status: RECRUITING
-
Early Diagnosis of Pancreatic Cancer Via Deciphering Multi-modal Immunological Signatures
NCT06495749 ·Status: NOT_YET_RECRUITING
-
MSCAN: ctDNA Methylation as Prognostic and Theranostic Tool for Pancreatic Cancer
NCT07045571 ·Status: RECRUITING
-
Prospectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis
NCT02869802 ·Status: RECRUITING
-
Studying Biomarkers in Patients With Pancreatic Cancer
NCT00900003 ·Status: COMPLETED
-
Diagnosis and Survival Prediction of Pancreatic Cancer by Machine Learning of Image Data
NCT05313854 ·Status: UNKNOWN
-
Profiling the Intratumoral Microbiome of Pancreatic Ductal Adenocarcinoma Based on EUS-FNB Tissue Samples and Exploring Its Impact on Tumor Diagnosis and Prognosis.
NCT06655233 ·Status: RECRUITING
-
Magnetic Resonance Imaging for Better Selection of Pancreatic Cancer Patients for Surgery: A Randomized Clinical Trial
NCT05253313 ·Status: UNKNOWN ·Phase: NA
-
Construction and Clinical Application of the Immune Map of Pancreatic Cancer Evolution
NCT07034339 ·Status: RECRUITING
-
Multi-omics Model for Pancreatic Cancer Screening Using cfDNA
NCT06456281 ·Status: RECRUITING
-
The Detection of CTCs in Patients With Pancreatic Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment.
NCT02406846 ·Status: COMPLETED
-
Investigate Role of Metabolic Imaging in Predicting Tumor Response/Outcome After Pancreatic CA Tx
NCT00767273 ·Status: COMPLETED ·Phase: NA
-
Biomarkers in Predicting Response to Treatment in Patients Who Have Undergone Surgery for Pancreatic Cancer
NCT00897832 ·Status: COMPLETED
-
Circulating Cell-free Tumor DNA(ctDNA) in Pancreatic Cancer
NCT02934984 ·Status: UNKNOWN
-
Establish Diagnostic Models Based on Portal Venous Blood for Pancreatic Cancer
NCT04536220 ·Status: RECRUITING